Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Hetero Drugs Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014375
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom research and manufacturing services to global biotechnology and pharmaceutical companies. Hetero offers products in various therapeutic areas which include HIV/AIDS, oncology, cardiovascular, neurology and hepatitis, among others. The company conducts research and development to develop new products. It markets its products through a network of marketing offices across the world. Hetero is headquartered in Hyderabad, Telangana, India.

Hetero Drugs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 11
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 12
Cipla Enters into Co-Marketing Agreement with Hetero Drugs 13
Furen Pharma to Form JV with Hetero Drugs for Oncology and AIDS 14
DFH Pharma Enters Into R&D Agreement With Hetero For HIV Drugs 15
Hetero Drugs Forms Joint Venture With Neopharma 16
Licensing Agreements 17
Hetero Enters into Licensing Agreement with VIVUS for STENDRA 17
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 18
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 19
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 20
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 21
Dr Reddy’s Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir 23
Gilead Sciences Enters into Licensing Agreement with Hetero Labs 24
Gilead Sciences Extends Licensing Agreement With Hetero Drugs For Tenofovir, Elvitegravir, Cobicistat And Quad 25
Tibotec Pharma Enters Into Licensing Agreement With Hetero Drugs For TMC278 26
Hetero Drugs Ltd – Key Competitors 27
Hetero Drugs Ltd – Key Employees 28
Hetero Drugs Ltd – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Joint Venture 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hetero Drugs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hetero Drugs Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Hetero Drugs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Oasmia Pharma Enters into Marketing and Distribution Agreement with Hetero Drugs 11
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 12
Cipla Enters into Co-Marketing Agreement with Hetero Drugs 13
Furen Pharma to Form JV with Hetero Drugs for Oncology and AIDS 14
DFH Pharma Enters Into R&D Agreement With Hetero For HIV Drugs 15
Hetero Drugs Forms Joint Venture With Neopharma 16
Hetero Enters into Licensing Agreement with VIVUS for STENDRA 17
Aurobindo Pharma, Cipla, Desano Pharma, Emcure Pharma, Hetero Labs and Laurus Labs Enter into Licensing Agreement with Medicines Patent Pool 18
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 19
Hetero Labs Enters into Licensing Agreement with Medicines Patent Pool 20
Cipla, Emcure Pharma, Hetero Drugs, Natco Pharma and Aurobindo Pharma Enter into Licensing Agreement with Medicines Patent Pool and Bristol-Myers Squibb 21
Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir 23
Gilead Sciences Enters into Licensing Agreement with Hetero Labs 24
Gilead Sciences Extends Licensing Agreement With Hetero Drugs For Tenofovir, Elvitegravir, Cobicistat And Quad 25
Tibotec Pharma Enters Into Licensing Agreement With Hetero Drugs For TMC278 26
Hetero Drugs Ltd, Key Competitors 27
Hetero Drugs Ltd, Key Employees 28
Hetero Drugs Ltd, Other Locations 29
Hetero Drugs Ltd, Subsidiaries 29
Hetero Drugs Ltd, Joint Venture 30

★海外企業調査レポート[Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Realm Therapeutics Plc (RLM):製薬・医療:M&Aディール及び事業提携情報
    Summary Realm Therapeutics Plc (Realm Therapeutics), formerly PuriCore Plc is a biopharmaceutical company that develops small molecule therapies for diseases. The company uses its immunomodulatory technology for treating inflammatory diseases in dermatology, ophthalmology, and other diseases. Its pi …
  • MMX Mineracao e Metalicos SA:企業の戦略・SWOT・財務分析
    MMX Mineracao e Metalicos SA - Strategy, SWOT and Corporate Finance Report Summary MMX Mineracao e Metalicos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lilis Energy Inc (LLEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Lilis Energy Inc (Lilis Energy), formerly Recovery Energy Inc is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in the Permian's Delaware Basin. The company identifies drilling locations for multi-horizon un …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ResApp Health Ltd (RAP):企業の財務・戦略的SWOT分析
    ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Petrolympic Ltd (PCQ):企業の財務・戦略的SWOT分析
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • OSRAM Opto Semiconductors GmbH:企業の戦略的SWOT分析
    OSRAM Opto Semiconductors GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Nampak Limited:企業の戦略・SWOT・財務分析
    Nampak Limited - Strategy, SWOT and Corporate Finance Report Summary Nampak Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Second Cup Ltd.:企業の戦略・SWOT・財務分析
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務分析
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Black River Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Black River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Apoteket AB:企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Christian Dior SE:企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Animal Health International Inc:企業の戦略的SWOT分析
    Animal Health International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Empresa Nacional del Petroleo:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Samsung SDS Co Ltd (018260):企業の財務・戦略的SWOT分析
    Samsung SDS Co Ltd (018260) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Aston Martin Lagonda Global Holdings plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Oxurion NV (OXUR):企業の財務・戦略的SWOT分析
    Oxurion NV (OXUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • QNB Finansbank (FINBN):企業の財務・戦略的SWOT分析
    QNB Finansbank (FINBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆